According to the authors, irisin could be used in the diagnosis of sarcopenia, thus preventing its consequences in subjects with cancer, while TNF-α appears to play a role in its pathophysiology by inhibiting protein synthesis in muscle cells. This evidence concerns the gene TNF and sarcopenia.